S. Annunziata

Discipline

Histoire, Philosophie et Sociologie des sciences (1)

Type de document

Articles (19) Recensions (3)

Co-auteur

Date

Source

Mot-clé

animal domestique (tenu en appartement) (16) Patients (15) Patients (15) Imaging (13) littérature (12) Literature (12) cancer (11) Cancer (11) Cancer (11) Nuclear medicine (10) Utilization (9) investigation (8) Performance (8) Detection (8) Performance (8) Tomography, Emission (7) Radiopharmaceuticals (7) membrane (6) Tumors (6) Tomography (6) Meta-analysis (6) Tomography (6) test (5) oncologie (5) analyse (5) Prostate (5) Positrons--Emission (5) Paper (5) Oncology (5) Authors (5)

Documents écrit par S. Annunziata (19) | parle de S. Annunziata (0)

Diagnostic yield of FAP-guided positron emission tomography in thyroid cancer: a systematic review.
A. Rizzo et al. (2024)
Diagnostic Accuracy of [68Ga]Ga Labeled Fibroblast-Activation Protein Inhibitors in Detecting Head and Neck Cancer Lesions Using Positron Emission Tomography: A Systematic Review and a Meta-Analysis.
A. Rizzo et al. (30 nov. 2023)
Diagnostic Performance of Positron Emission Tomography with Fibroblast-Activating Protein Inhibitors in Gastric Cancer: A Systematic Review and Meta-Analysis.
A. Rizzo et al. (14 juin 2023)
18F-FDG PET/CT Maximum Tumor Dissemination (Dmax) in Lymphoma: A New Prognostic Factor?
D. Albano et al. (26 avr. 2023)
Baseline 18F-FDG PET/CT Radiomics in Classical Hodgkin’s Lymphoma: The Predictive Role of the Largest and the Hottest Lesions.
EKA Triumbari et al. (11 avr. 2023)
Potential Role of PSMA-Targeted PET in Thyroid Malignant Disease: A Systematic Review.
A. Rizzo et al. (3 févr. 2023)
The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review.
A. Rizzo et al. (5 janv. 2023)
Editorial: Radiomics and artificial intelligence in radiology and nuclear medicine.
S. Annunziata et al. (2023)
Contrast enhanced CT on PET/CT imaging in clinical routine: an international survey.
S. Annunziata et al. (2023)
Artificial Intelligence in the Diagnosis of Hepatocellular Carcinoma: A Systematic Review.
A. Martinino et al. (28 oct. 2022)
PSMA Radioligand Uptake as a Biomarker of Neoangiogenesis in Solid Tumours: Diagnostic or Theragnostic Factor?
A. Rizzo et al. (21 août 2022)
18F-Fluoroethylcholine PET/CT Radiomic Analysis for Newly Diagnosed Prostate Cancer Patients: A Monocentric Study.
D.A. Pizzuto et al. (14 août 2022)
Diagnostic Accuracy of PET/CT or PET/MRI Using PSMA-Targeting Radiopharmaceuticals in High-Grade Gliomas: A Systematic Review and a Bivariate Meta-Analysis.
B. Muoio et al. (8 juil. 2022)
Radiomics in Oncological PET Imaging: A Systematic Review-Part 1, Supradiaphragmatic Cancers.
D. Morland et al. (27 mai 2022)
Radiomics in Oncological PET Imaging: A Systematic Review-Part 2, Infradiaphragmatic Cancers, Blood Malignancies, Melanoma and Musculoskeletal Cancers.
D. Morland et al. (27 mai 2022)
Healthy Organs Uptake on Baseline 18F-FDG PET/CT as an Alternative to Total Metabolic Tumor Volume to Predict Event-Free Survival in Classical Hodgkin's Lymphoma.
D. Morland et al. (2022)
PET with Different Radiopharmaceuticals in Neuroendocrine Neoplasms: An Umbrella Review of Published Meta-Analyses.
G. Treglia et al. (15 oct. 2021)
Diagnostic Performance of PET Imaging Using Different Radiopharmaceuticals in Prostate Cancer According to Published Meta-Analyses.
S. Annunziata et al. (4 août 2020)
Detection Rate of (18)F-Labeled PSMA PET/CT in Biochemical Recurrent Prostate Cancer: A Systematic Review and a Meta-Analysis.
G. Treglia et al. (23 mai 2019)